Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties
- 1 February 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59, S42-S47
- https://doi.org/10.1046/j.1523-1755.2001.59780042.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Growth factors VEGF and TGF-β1 in peritoneal dialysisJournal of Laboratory and Clinical Medicine, 1999
- Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtrationNephrology Dialysis Transplantation, 1999
- Peritoneal dialysis adequacy: A model to assess feasibility with various modalitiesKidney International, 1999
- Osmotic agents and buffers in peritoneal dialysis solution: Monocyte cytokine release and in vitro cytotoxicityAmerican Journal of Kidney Diseases, 1997
- Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesisKidney International, 1995
- Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.Proceedings of the National Academy of Sciences, 1994
- Structural Causes of Cardiac Dysfunction in UremiaRenal Failure, 1993
- Pathogenesis of Peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal DialysisPeritoneal Dialysis International, 1992
- Clinical Value of Standardized Equilibration Tests in CAPD PatientsBlood Purification, 1989
- Morphology of the Peritoneal Membrane during Continuous Ambulatory Peritoneal DialysisNephron, 1986